Pharmacogenetic Variants in the and Genes are Clinically Significant Predictors of Fluoropyrimidine Toxicity: Are We Ready for Use in our Clinical Practice.
作者信息
Saif Muhammad Wasif, Hachem Hilal, Purvey Sneha, Hamal Ruchi, Zhang Lulu, Siddiqui Nauman Saleem, Godara Amandeep, Diasio Robert B
机构信息
Northwell Health Cancer Institute, Lake Success, NY 11042, USA.
Tufts Medical Center, Boston, MA, 02110, USA.
出版信息
Arch Pharmacol Ther. 2020;2(1):6-8.
Abstract
摘要
相似文献
1
2
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity.DPYD、TYMS、CDA 和 MTHFR 基因中的药物遗传学变异是氟嘧啶类毒性的临床显著预测因子。
Br J Cancer. 2013 Jun 25;108(12):2505-15. doi: 10.1038/bjc.2013.262. Epub 2013 Jun 4.
3
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.基于 DPYD 基因型的氟嘧啶类药物个体化剂量在癌症患者中的应用：一项前瞻性安全性分析。
Lancet Oncol. 2018 Nov;19(11):1459-1467. doi: 10.1016/S1470-2045(18)30686-7. Epub 2018 Oct 19.
4
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity.治疗前血清尿嘧啶浓度作为严重和致命性氟嘧啶相关毒性的预测指标。
Br J Cancer. 2017 May 23;116(11):1415-1424. doi: 10.1038/bjc.2017.94. Epub 2017 Apr 20.
5
DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update.基于二氢嘧啶脱氢酶（DPYD）基因型的剂量个体化以提高氟嘧啶类药物治疗的患者安全性：呼吁更新药品标签
Ann Oncol. 2017 Dec 1;28(12):2915-2922. doi: 10.1093/annonc/mdx411.
6
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines.荷兰药物遗传学工作组（DPWG）关于 DPYD 和氟嘧啶类药物基因-药物相互作用的指南。
Eur J Hum Genet. 2020 Apr;28(4):508-517. doi: 10.1038/s41431-019-0540-0. Epub 2019 Nov 19.
7
Implementing DPYD*2A Genotyping in Clinical Practice: The Quebec, Canada, Experience.在临床实践中实施 DPYD*2A 基因分型：加拿大魁北克的经验。
Oncologist. 2021 Apr;26(4):e597-e602. doi: 10.1002/onco.13626. Epub 2020 Dec 23.
8
The Role of and Polymorphisms in Fluoropyrimidine-Based Cancer Chemotherapy in an Iranian Population.某伊朗人群中[具体基因名称]和[具体基因名称]多态性在基于氟嘧啶的癌症化疗中的作用
Avicenna J Med Biotechnol. 2020 Jul-Sep;12(3):157-164.
9
Pathogenic DPYD Variants and Treatment-Related Mortality in Patients Receiving Fluoropyrimidine Chemotherapy: A Systematic Review and Meta-Analysis.携带致病变异型 DPYD 的患者接受氟嘧啶化疗的相关治疗死亡率：系统评价和荟萃分析。
Oncologist. 2021 Dec;26(12):1008-1016. doi: 10.1002/onco.13967. Epub 2021 Sep 29.
10
Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines.双氢嘧啶脱氢酶（DPYD）基因c.1129-5923C>G纯合子/单倍型B3的患者存在部分双氢嘧啶脱氢酶缺乏，在接受氟嘧啶治疗时需要减少剂量。
Cancer Chemother Pharmacol. 2016 Oct;78(4):875-80. doi: 10.1007/s00280-016-3137-0. Epub 2016 Aug 20.
引用本文的文献
1
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer.一项关于生殖系药物基因组学对成年癌症患者严重毒性和症状负担影响的系统评价和荟萃分析。
Clin Transl Sci. 2024 May;17(5):e13781. doi: 10.1111/cts.13781.
2
Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects.结直肠癌中5-氟尿嘧啶耐药机制综述：减弱的靶向效应的临床意义
Cancer Drug Resist. 2023 Apr 29;6(2):257-272. doi: 10.20517/cdr.2022.136. eCollection 2023.
3
Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).氟尿嘧啶类药物诱导的结直肠癌患者心脏毒性：一项前瞻性观察性试验（CHECKPOINT）。
Oncol Rep. 2023 Feb;49(2). doi: 10.3892/or.2022.8468. Epub 2022 Dec 23.
4
A narrative review of genetic factors affecting fluoropyrimidine toxicity.影响氟嘧啶毒性的遗传因素的叙述性综述。
Precis Cancer Med. 2021 Dec;4. doi: 10.21037/pcm-21-17. Epub 2021 Dec 30.
5
Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes.胸苷酸合成酶和二氢嘧啶脱氢酶基因发生突变的肛管癌患者的替代放化疗
Therap Adv Gastroenterol. 2021 Jul 3;14:17562848211024464. doi: 10.1177/17562848211024464. eCollection 2021.
本文引用的文献
1
Capecitabine-induced cerebellar toxicity and TYMS pharmacogenetics.卡培他滨诱导的小脑毒性与胸苷酸合成酶药物遗传学
Anticancer Drugs. 2019 Apr;30(4):431-434. doi: 10.1097/CAD.0000000000000737.
2
First Case of Foot Drop Associated with Capecitabine in a Patient with Thymidylate Synthase Polymorphism.胸苷酸合成酶基因多态性患者中首例与卡培他滨相关的足下垂病例
Cureus. 2017 Jan 24;9(1):e995. doi: 10.7759/cureus.995.
3
Pancytopenia and Severe Gastrointestinal Toxicities Associated with 5-Fluorouracil in a Patient with Thymidylate Synthase (TYMS) Polymorphism.一名胸苷酸合成酶（TYMS）基因多态性患者出现与5-氟尿嘧啶相关的全血细胞减少和严重胃肠道毒性
Cureus. 2016 Sep 21;8(9):e798. doi: 10.7759/cureus.798.
4
The First Case of Severe Takotsubo Cardiomyopathy Associated with 5-Fluorouracil in a Patient with Abnormalities of Both Dihydropyrimidine Dehydrogenase (DPYD) and Thymidylate Synthase (TYMS) Genes.二氢嘧啶脱氢酶（DPYD）和胸苷酸合成酶（TYMS）基因均异常的患者中首例与5-氟尿嘧啶相关的严重应激性心肌病病例。
Cureus. 2016 Sep 14;8(9):e783. doi: 10.7759/cureus.783.
5
Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.尿苷三乙酸酯在预防和治疗危及生命的5-氟尿嘧啶和卡培他滨毒性中的紧急使用。
Cancer. 2017 Jan 1;123(2):345-356. doi: 10.1002/cncr.30321. Epub 2016 Sep 13.
6
Benefit of uridine triacetate (Vistogard) in rescuing severe 5-fluorouracil toxicity in patients with dihydropyrimidine dehydrogenase (DPYD) deficiency.三醋酸尿苷（Vistogard）在挽救二氢嘧啶脱氢酶（DPYD）缺乏患者严重5-氟尿嘧啶毒性方面的益处。
Cancer Chemother Pharmacol. 2016 Jul;78(1):151-6. doi: 10.1007/s00280-016-3063-1. Epub 2016 Jun 8.
7
TAS-102 an Emerging Oral Fluoropyrimidine.TAS-102：一种新型口服氟嘧啶类药物。
Anticancer Res. 2016 Jan;36(1):21-6.
8
A DPYD variant (Y186C) specific to individuals of African descent in a patient with life-threatening 5-FU toxic effects: potential for an individualized medicine approach.在一位发生危及生命的 5-FU 毒性反应的患者中发现了一种特定于非洲裔人群的 DPYD 变异体（Y186C）：个体化药物治疗的潜在可能性。
Mayo Clin Proc. 2014 Jan;89(1):131-136. doi: 10.1016/j.mayocp.2013.09.008.
9
10
Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in vitro measurement of enzyme activity.采用实时细胞分析和体外酶活性测定对与 5-氟尿嘧啶敏感性相关的 DPYD 变异进行表型谱分析。
Cancer Res. 2013 Mar 15;73(6):1958-68. doi: 10.1158/0008-5472.CAN-12-3858. Epub 2013 Jan 17.
Zotero 插件